Published in Vaccine Weekly, January 8th, 2003
The smallpox vaccine consists of a live vaccinia virus which produces an immune defense to smallpox infection in humans. The traditional method for determining the success of vaccination against smallpox was a subjective observation of the presence of a lesion or scar by a healthcare professional.
The gold standard laboratory test, the plaque reduction neutralization test...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly